Trade KRRO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Korro Bio, Inc. (KRRO) is trading at US$10.16, down 3.97% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$194.08M. Over the past 52 weeks, KRRO has traded between US$5.20 and US$55.89. On Syfe you can trade KRRO with $0 commission and add it to your watchlist.
| Previous close | US$10.58 |
|---|---|
| Market cap | US$194.08M |
| 52-week range | US$5.20 – US$55.89 |
| Volume | 130.09K |
| Exchange | US |
Korro Bio, Inc.
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Year: 2023
Korro Bio Insider Sold Shares Worth $1,542,970, According to a Recent SEC Filing
Jul 8, 8:06 AM · MT Newswires
Korro Bio Insider Sold Shares Worth $2,458,582, According to a Recent SEC Filing
Jun 25, 8:07 AM · MT Newswires
Citigroup Initiates Korro Bio at Buy With $21 Price Target
May 18, 11:39 AM · MT Newswires
Korro Bio, Inc. (KRRO) stock is trading at US$10.16, -3.97% from the previous close of US$10.58.
The market cap for Korro Bio, Inc. (KRRO) stock is approximately US$194.08M.
The 52-week high for Korro Bio, Inc. (KRRO) stock is US$55.89.
The 52-week low for Korro Bio, Inc. (KRRO) stock is US$5.20.
Korro Bio, Inc. (KRRO) does not currently pay a dividend.
Stay on top of KRRO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
